Baclofen Should NOT Be Used for Chronic Low Back Pain
Based on the highest quality guideline evidence, baclofen is not recommended for chronic low back pain because there is little evidence for its efficacy in this condition 1. The American College of Physicians/American Pain Society joint clinical practice guideline explicitly states that "there is little evidence for the efficacy of baclofen or dantrolene, the other FDA-approved drugs for the treatment of spasticity" when used for low back pain 1.
Why Baclofen Is Not Appropriate
The FDA-approved indication for baclofen is specifically for spasticity resulting from multiple sclerosis and spinal cord diseases—not for musculoskeletal pain or muscle spasm from low back pain 2. The FDA label explicitly states: "Baclofen tablets are not indicated in the treatment of skeletal muscle spasm resulting from rheumatic disorders" 2. Chronic low back pain with muscle spasm falls into this category of rheumatic/musculoskeletal disorders, not spasticity.
Key Distinction: Spasticity vs. Muscle Spasm
- Spasticity = velocity-dependent increase in muscle tone from upper motor neuron lesions (MS, spinal cord injury)
- Muscle spasm in low back pain = protective muscular contraction from musculoskeletal pain, NOT spasticity
What Should Be Used Instead
First-Line Options for Chronic Low Back Pain:
- Acetaminophen (up to 4g/day) - safer profile, though slightly less effective than NSAIDs 1
- NSAIDs - small effect on pain (MD -6.97 on 0-100 scale) and disability, but assess cardiovascular/GI risk first 3, 4
Second-Line Options:
- Tricyclic antidepressants for chronic low back pain without contraindications 1
- Duloxetine (SNRI) - small but proven benefit for chronic low back pain 3
- Tramadol or opioids - only for severe, disabling pain uncontrolled by acetaminophen/NSAIDs, used judiciously with time-limited courses 1
Other Muscle Relaxants (If Truly Needed):
If a muscle relaxant is absolutely necessary for acute low back pain (not chronic), tizanidine has been better studied than baclofen for low back pain 1. However, even these are only recommended for short-term relief of acute low back pain, not chronic pain 1.
Critical Safety Concerns with Baclofen
Recent evidence shows significant safety issues:
- Higher risk of injury (HR 1.54) and delirium (HR 3.33) compared to tizanidine in older adults 5
- CNS adverse effects including sedation, weakness, and cognitive impairment 6
- Abrupt withdrawal risk: seizures, psychic symptoms, and hyperthermia can occur 2, 7
- Older adults rarely tolerate doses >30-40 mg/day 6
If Baclofen Were to Be Used (Against Recommendations)
Since the evidence does not support its use for chronic low back pain, specific dosing recommendations for this indication do not exist. The FDA-approved titration schedule is designed for spasticity 2:
- Start: 5 mg three times daily for 3 days
- Increase: 10 mg TID for 3 days, then 15 mg TID for 3 days, then 20 mg TID for 3 days
- Maximum: 80 mg/day (20 mg four times daily)
- Never discontinue abruptly - must taper slowly to avoid withdrawal syndrome 2
Monitoring Requirements:
- Muscle weakness and sedation (most common)
- Cognitive effects and urinary function
- Renal function (baclofen is renally cleared; accumulation risk in renal impairment) 8, 7
Bottom Line
Do not prescribe baclofen for chronic low back pain. Use acetaminophen or NSAIDs as first-line therapy, with tricyclic antidepressants or duloxetine as alternatives for chronic pain 1, 3. The 2024 systematic review confirms that long-term muscle relaxant use for low back pain is not beneficial 9, and the most recent Cochrane overview found no high-certainty evidence supporting any muscle relaxant for chronic low back pain 4.